Clinical significance of coagulase-negative staphylococci isolates from nosocomial bloodstream infections

References

• Widerstrom M, Wistrom J, Sjostedt A, Monsen T. Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis. 2012;31:7–20.
   PubMed Web of Science ®Google Scholar
• Novakova D, Pantucek R, Hubalek Z, et al. Staphylococcus microti sp. nov., isolated from the common vole (Microtus arvalis). Int J Syst Evol Microbiol. 2010;60:566–573.
   PubMed Web of Science ®Google Scholar
• Casey AL, Lambert PA, Elliott TS. Staphylococci. Int J Antimicrob Agents. 2007;29:S23–32.
   PubMed Web of Science ®Google Scholar
• Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol. 2005;26:559–566.
   PubMed Web of Science ®Google Scholar
• Olaechea PM, Alvarez-Lerma F, Palomar M, et al. Impact of primary and intravascular catheter-related bacteremia due to coagulase-negative staphylococci in critically ill patients. Med Intensiva. 2011;35:217–225.
   PubMed Web of Science ®Google Scholar
• Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 2009;23:73–98.
   PubMed Web of Science ®Google Scholar
• Považan A, Vukelić A, Kurucini T, et al. Non-susceptibility trends among methicillin-resistant coagulase-negative staphylococci isolated from blood cultures. Arch Biol Sci Belgrade. 2014;66:79–86.
   Web of Science ®Google Scholar
• Cremniter J, Slassi A, Quincampoix JC, et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol. 2010;48:1428–431.
   PubMed Web of Science ®Google Scholar
• Molina J, Penuela I, Lepe JA, et al. Mortality and hospital stay related to coagulase negative staphylococci bacteremia in non-critical patients. J Infect. 2013;66:155–162.
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Wolfe RE, Wright S, et al. Who needs a blood culture? A prospectively validated clinical prediction rule. Acad Emerg Med. 2003;10:435–436.
   Google Scholar
• Elzi L, Babouee B, Geli NV, et al. How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect. 2012;18:E355–E361.
   PubMed Web of Science ®Google Scholar
• Schnell D, Cuyer H, Geeraerts T, et al. Preliminary evaluation of a new clinical algorithm to interpret blood cultures growing coagulase-negative staphylococci. Scand J Infect Dis. 2013;45:562–566.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49:1–45.
   PubMed Web of Science ®Google Scholar
• Tashiro M, Izumikawa K, Ashizawa N, et al. Clinical significance of methicillin-resistant coagulase-negative staphylococci obtained from sterile specimens. Diagn Microbiol Infect Dis. 2015;81:71–75.
   PubMed Web of Science ®Google Scholar
• Erjavec Z, de Vries-Hospers HG, Laseur M, et al. A prospective, randomized, double-blinded, placebo controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother. 2000;45:843–849.
   PubMed Web of Science ®Google Scholar
• Kullar R, Davis SL, Levine DP, et al. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011;31:527–536.
   PubMed Web of Science ®Google Scholar
• Surveillance of Nosocomial Infections in Intensive Care Units. Master protocol: hospital in Europe link for infection control through surveillance (HELICS) [Internet]. 2004 [cited 2015 Oct 01]. Available from: http://www.ecdc.europa.eu/IPSE/protocols/icu_protocols.pdf.
   Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–332.
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing: 24th Informational Supplement. M100-S24. Clinical and Laboratory Standards Institute; 2014.
   Google Scholar
• Maes N, Magdalena J, Rottiers S, et al. Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol. 2002;40:1514–1517.
   PubMed Web of Science ®Google Scholar
• Marra AR, Camargo LF, Pignatari AC, et al; Brazilian SCOPE Study Group. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49:1866–1871.
   PubMed Web of Science ®Google Scholar
• Natoli S, Fontana C, Favaro M, et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect Dis. 2009;9:83.
   PubMed Web of Science ®Google Scholar
• Glickman SW, Krubert C, Koppenhaver J, et al. Increased rate of central venous catheterization procedures in community EDs. Am J Emerg Med. 2010;28:208–212.
   PubMed Web of Science ®Google Scholar
• Abdul Rahman Z, Hamzah SH, Hassan SA, et al. The significance of coagulase-negative staphylococci bacteremia in a low resource setting. J Infect Dev Ctries. 2013;7:448–452.
   PubMed Web of Science ®Google Scholar
• Stuart JI, John MA, Milburn S, et al. Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin. Int J Antimicrob Agents. 2011;37:248–252.
   PubMed Web of Science ®Google Scholar
• Sader HS, Jones RN. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus. Diagn Microbiol Infect Dis. 2012;73:212–214.
   PubMed Web of Science ®Google Scholar
• Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res. 2009;164:404–410.
   PubMed Web of Science ®Google Scholar
• Sharma V, Jindal N, Devi P. Prevalence of methicillin resistant coagulase negative staphylococci in a tertiary care hospital. Iran J Microbiol. 2010;4:185–188.
   Google Scholar
• Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;335:653–665.
   Web of Science ®Google Scholar